USPTO serial 99338269
GENINVO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 31, 2026
- Examiner
- MCPHERSON RAYBURN, SHAVELL A
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GENINVO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Bloomington, IL, US
Bloomington, IL, US
Bloomington, IL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew Saunders
Matthew Saunders Saunders & Silverstein LLP14 Cedar Street, Suite 224Amesbury, MA 01913United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting services for pharmaceutical and life sciences companies in the fields of clinical research, clinical trials, and applications for drug approval; Business data analytics and business data management services in the pharmaceutical and life sciences fields of clinical research; Business consulting and management in the field of clinical trials, namely, clinical data management on behalf of pharmaceutical and life sciences companies to assist them with clinical research and clinical trials; Providing independent review of clinical trial data for business purposes | ACTIVE | — |
| 042 | Providing temporary use of online non-downloadable software and software applications for data management and data analysis in the nature of clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; providing temporary use of online non-downloadable software and software applications using artificial intelligence (AI) for data management and data analysis in the nature of clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; Custom design of computer application software; Technical support services, namely, cloud managed services in the nature of remote infrastructure management services for migration, configuration, monitoring, and management of cloud computing IT systems and cloud databases; Providing quality control services in the fields of clinical research, clinical trials, and applications for drug approval; Providing independent review of clinical trial data for medical or scientific purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 31, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 31, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 10, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 10, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 13, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 13, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 31, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 31, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 31, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 31, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 30, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 14, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 14, 2025 | NWAP | NEW APPLICATION ENTERED | — |